Search
for

    Glossary Prostate Volume

    measurement of the prostate gland's size in cubic centimeters

    Prostate Volume, also known as Prostate Size or Prostatic Volume, refers to the measurement of the prostate gland's size, typically expressed in cubic centimeters (cc) or milliliters (mL). This measurement is important for diagnosing and managing conditions like benign prostatic hyperplasia (BPH) and prostate cancer. It is usually determined through imaging techniques such as ultrasound or MRI.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Prostate volume and its relationship with anthropometric variables among different ethnic groups of South-Kivu, DR Congo African Journal of Urology · 2020 · 6 citations
    2. Effects of the use of finasteride on prostate volume and serum PSA in young patients Digital Library of Theses and Dissertations (Universidade de São Paulo) · 2015
    3. 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY The Journal of Urology · 2010
    4. Androgen Receptor Gene Polymorphism and Prostate Zonal Volumes in Australian and Chinese Men Journal of Andrology · 2000 · 34 citations
    5. Total prostate volume as risk factor for semen pathologies in ageing male Journal of Men's Health · 2010
    6. UP-02.009 Clinical Significance of Intravesical Prostatic Protrusion/Prostate Volume Urology · 2011
    7. DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA 2004 · 235 citations
    8. Role of 5 alpha-reductase inhibitors in the management of prostate cancer Clinical interventions in aging · 2006 · 15 citations
    9. Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms. PubMed · 2019 · 1 citations
    10. EFFECT OF A COMBINATION OF DUTASTERIDE AND PARENTERAL TESTOSTERONE UNDECANOATE ON TESTOSTERONE DEFICIENCY SYMPTOMS AND PROSTATE IN PATIENTS WITH TESTOSTERONE DEFICIENCY AND BENIGN PROSTATIC HYPERPLASIA Journal of Men s Health · 2020
    11. Efeitos do uso da finasterida sobre o volume prostático e dosagem sérica do PSA em pacientes jovens 2017
    12. 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA The Journal of Urology · 2010
    13. Finasteride-its impact on sexual function and prostate cancer Journal of Cutaneous and Aesthetic Surgery · 2009 · 33 citations
    14. Alopecia androgénica como factor predictor de hiperplasia benigna de próstata Universidad Privada Antenor Orrego · 2018
    15. Finasteride Drugs · 1999 · 125 citations
    16. Urinary Retention in Patients with BPH Treated with Finasteride or Placebo over 4 Years European Urology · 2000 · 109 citations
    17. CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN The Journal of Urology · 1999 · 104 citations
    18. Acute urinary retention: risks and management. PubMed · 2005 · 46 citations
    19. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    20. Androgenetic alopecia as an early marker of benign prostatic hyperplasia Journal of The American Academy of Dermatology · 2011 · 28 citations
    21. Meta-Analysis of Randomized Clinical Trials of Finasteride Urology · 1998 · 21 citations
    22. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    23. Finasterida: Diez Años De Uso Clínico. Revisión Sistemática De La Literatura Actas Urológicas Españolas · 2003 · 14 citations
    24. Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency Endocrine journal · 2019 · 13 citations
    25. Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients European Urology Supplements · 2003 · 12 citations
    26. Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia The Journal of Urology · 2012 · 5 citations
    27. Gleason grading controversies: what the chemoprevention trials have taught us Canadian Urological Association Journal · 2013 · 4 citations
    28. Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 3 citations
    29. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–I Mayo Clinic Proceedings · 2006 · 2 citations
    30. Features of hyperandrogenism in men Problemy e̊ndokrinologii · 2021 · 1 citations